Stem Cell Research

Long-term survival of blood stem cells reported in cloning and stem cells

Published in Gene Therapy Weekly, July 28th, 2005

Therapeutic cloning, a technique aimed at producing stem cells for use in tissue replacement therapy to treat human degenerative diseases, will only be successful if the transplanted stem cells are able to survive and multiply over time.

Evidence of such long-term survival has now been reported in the June 2005 (7:2) issue of Cloning and Stem Cells, a peer-reviewed journal published by Mary Ann Liebert, Inc.

Robert Lanza, MD, vice president of medical and scientific Development, Advanced Cell Technology, Worcester, Massachusetts, and colleagues used nuclear transfer to produce cloned fetuses from the cells of old cows. They then isolated blood...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2005-07-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry